Howden CW - Search Results

1

Re-evaluating the Proposed Association Between Vonoprazan and Gastric Cancer Following Eradication of H. pylori Infection.

Howden CW, Chey WD, Shah SC. Howden CW, et al. Clin Gastroenterol Hepatol. 2025 Jan;23(1):182-183. doi: 10.1016/j.cgh.2024.04.015. Epub 2024 May 8. Clin Gastroenterol Hepatol. 2025. PMID: 38729385 No abstract available.

2

Reply.

Chey WD, Howden CW. Chey WD, et al. Among authors: howden cw. Gastroenterology. 2023 Apr;164(4):699-700. doi: 10.1053/j.gastro.2022.11.011. Epub 2022 Nov 13. Gastroenterology. 2023. PMID: 36379243 No abstract available.

3

Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon-HP trial.

Chey WD, Mégraud F, Laine L, Smith N, Leifke E, Hunt B, Howden CW. Chey WD, et al. Among authors: howden cw. JGH Open. 2024 Nov 15;8(11):e70044. doi: 10.1002/jgh3.70044. eCollection 2024 Nov. JGH Open. 2024. PMID: 39554983 Free PMC article.

4

Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia.

Ford AC, Howden CW. Ford AC, et al. Among authors: howden cw. Clin Gastroenterol Hepatol. 2023 Oct;21(11):2986-2987. doi: 10.1016/j.cgh.2023.02.001. Epub 2023 Feb 17. Clin Gastroenterol Hepatol. 2023. PMID: 36806626 No abstract available.

5

Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan.

Howden CW, Cook EE, Swallow E, Yang K, Guo H, Pelletier C, Jacob R, Sugano K. Howden CW, et al. Therap Adv Gastroenterol. 2023 May 2;16:17562848231168714. doi: 10.1177/17562848231168714. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37153499 Free PMC article.

6

Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection.

Howden CW, Spechler SJ, Vaezi MF, Fendrick AM, Atkinson C, Pelletier C, Jacob R, Brunton S. Howden CW, et al. Gastro Hep Adv. 2022 Feb 3;1(2):231-240. doi: 10.1016/j.gastha.2021.12.005. eCollection 2022. Gastro Hep Adv. 2022. PMID: 39131129 Free PMC article.

7

Response to Graham.

Laine L, Sharma P, Mulford DJ, Hunt B, Leifke E, Smith N, Howden CW. Laine L, et al. Among authors: howden cw. Am J Gastroenterol. 2022 Nov 1;117(11):1882-1883. doi: 10.14309/ajg.0000000000002009. Am J Gastroenterol. 2022. PMID: 36327440 No abstract available.

8

[No title available]

[No authors listed] [No authors listed] PMID: 38085944

9

Integrated Analysis of Vonoprazan Safety for Symptomatic Gastro-Oesophageal Reflux Disease or Erosive Oesophagitis.

Howden CW, Katz P, DeVault KR, Metz DC, Tamene D, Smith N, Hunt B, Chang YM, Spechler SJ. Howden CW, et al. Aliment Pharmacol Ther. 2024 Dec 25. doi: 10.1111/apt.18458. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 39720884

10

Mathematical model of the relationship between pH holding time and erosive esophagitis healing rates.

Howden CW, Scarpignato C, Leifke E, Mulford DJ, Lahu G, Facius A, Yuan Y, Hunt R. Howden CW, et al. CPT Pharmacometrics Syst Pharmacol. 2025 Jan;14(1):28-41. doi: 10.1002/psp4.13235. Epub 2024 Sep 19. CPT Pharmacometrics Syst Pharmacol. 2025. PMID: 39297248 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters